Here's Why Sutro Biopharma (NASDAQ:STRO) Must Use Its Cash Wisely [Yahoo! Finance]
Sutro Biopharma, Inc. (STRO)
Last sutro biopharma, inc. earnings: 11/8 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
after listing, if you had bought and held the shares since 1999, you would have made a fortune. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So, the natural question for Sutro Biopharma NASDAQ:STRO ) shareholders is whether they should be concerned by its rate of cash burn. In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as the 'cash burn'. First, we'll determine its cash runway by comparing its cash burn with its cash reserves. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at March 2025, Sutro Biopharma had cash of US$249m and no debt. Importantly, its cash burn was US$199m over the trailing twelve months. That means it had a cash runway of around 15 months as of Ma
Show less
Read more
Impact Snapshot
Event Time:
STRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
STRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
STRO alerts
High impacting Sutro Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
STRO
News
- Ipsen outlays $1bn for China-based Simcere's preclinical ADC [Yahoo! Finance]Yahoo! Finance
- Sutro Biopharma (NASDAQ:STRO) had its price target raised by analysts at HC Wainwright from $2.00 to $10.00. They now have a "neutral" rating on the stock.MarketBeat
- Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewswire
- Sutro Biopharma (NASDAQ:STRO) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
STRO
Earnings
- 5/8/25 - Miss
STRO
Sec Filings
- 12/17/25 - Form 8-K
- 12/16/25 - Form 4
- 12/3/25 - Form 8-K
- STRO's page on the SEC website